Why not real economics?

PharmacoEconomics

Volumn 30, Issue 2, 2012, Pages 127-131

  Johnson, F Reed ^a  

^a RTI HEALTH SOLUTIONS   (United States)

Author keywords

Cost benefit; Cost effectiveness; Cost utility; Decision making.

Indexed keywords

HEALTH ECONOMICS; MEDICAL LITERATURE; NOTE; PRIORITY JOURNAL; PUBLICATION; TECHNOLOGY;

COST-BENEFIT ANALYSIS; ECONOMICS, MEDICAL; FINANCING, PERSONAL; HEALTH; HEALTH CARE RATIONING; HUMANS; OUTCOME ASSESSMENT (HEALTH CARE); PATIENT PREFERENCE; PHARMACEUTICAL PREPARATIONS; QUALITY-ADJUSTED LIFE YEARS; SOCIOECONOMIC FACTORS; TECHNOLOGY ASSESSMENT, BIOMEDICAL; VALUE OF LIFE;

EID: 84855874611     PISSN: 11707690     EISSN: 11792027     Source Type: Journal    
DOI: 10.2165/11593350-000000000-00000     Document Type: Note

References (19)

1. Torrance GW. Utility measurement in healthcare: the things I never got to. Pharmacoeconomics 2006; 24 (11): 1069-78 (Pubitemid 44683364)
2. Gold MR, Siegel JE, Russell LB, et al. Cost-effectiveness in health and medicine. New York: Oxford University Press, 1996
3. Pareto V. Manual of political economy [Schwier AS, trans- lator]. New York: Augustus M. Kelley, 1971
4. Bala MV, Zarkin GA. Are QALYs an appropriate measure for valuing morbidity in acute diseases? Health Econ 2000; 9 (2): 177-80 (Pubitemid 30148164)
5. Bridges JFP, Onukwugha E, Mullins CD. Healthcare ra- tioning by proxy: cost-effectiveness analysis and the misuse of the $50 000 threshold in the US. Pharmacoeconomics 2010; 28 (3): 175-84
6. The White House. Executive Order 12291. 46 Federal Reg- ister 13193, 3 CFR (1981) [online]. Available from URL: http://www.archives.gov/federal- register/codification/ex ecutive-order/12291.html [Accessed 2011 Jul 28]
7. The White House. Executive Order 12866. 58 Federal Register 190 (1993) [online]. Available from URL: http://www. reginfo.gov/public/jsp/Utilities/EO- 12866.pdf [Accessed 2011 Jul 28]
8. Office for Official Publications of the European Commu- nities. Financial and economic analysis of development projects. Luxembourg: European Commission 1997
9. Evaluation Unit, DG Regional Policy. Guide to cost-benefit analysis of investment projects: structural funds, cohesion fund and instrument for pre-accession. Milan: European Commission, 2008
10. Treasury Board of Canada Secretariat, Canadian cost- benefit analysis guide: regulatory proposals [catalogue no. BT58-5/2007]. Ottawa: Treasury Board of Canada Secretariat, 2007
11. Department of Finance and Deregulation. Best practice regulation handbook: Appendix E-cost-benefit analysis. Canberra (ACT): Australian Government 2008 [online]. Available from URL: http://www.finance.gov.au/obpr/ proposal/handbook/appendix-E-cost-benefit-analysis.html [Accessed 2011 Jul 28]
12. Bridges JFP, Kinter ET, Kidane L, et al. Things are looking up since we started listening to patients: trends in the application of conjoint analysis in health 1982-2007. Patient 2008; 1 (4): 273-82
13. Marshall D, Bridges JFP, Hauber AB, et al. Conjoint analysis applications in health: how are studies being designed and reported? An update on current practice in the published literature between 2005 and 2008. Patient 2010; 3 (4): 249-56
14. Hausman JA, editor. Contingent valuation: a critical assess- ment. New York: Elsevier Science and Technology, 1993
15. Endangered Species Act, 16 U.S.C. y 1531 (1973) [online]. Available from URL: http://epw.senate.gov/esa73.pdf [Accessed 2011 Jul 28]
16. Murchison KM. The snail darter case: TVA versus the En- dangered Species Act. Lawrence (KS): University Press of Kansas, 2007
17. Clean Air Act, 42 U.S.C. y 7401 (1970) [online]. Available from URL: http://epw.senate.gov/envlaws/cleanair.pdf [Accessed 2011 Jul 28]
18. Clean Water Act, 33 U.S.C. y 1251 (1972) [online]. Available from URL: http://epw.senate.gov/water.pdf [Accessed 2011 Jul 28]
19. Arrow KJ, Cropper ML, Eads GC, et al. Is there a role for benefit-cost analysis in environmental, health and safety regulation? Science 1996; 272: 221-2 (Pubitemid 26119132)